Jack W Britts is a high-skilled professional, who works in Azova Health as a Board Member since 2019. Jack has earned professional experience in more than nine positions at various companies. Jack W Britts went to the University of Richmond and received education from 1978 to 1982. Greensboro, North Carolina is the area, where this person was known to live. This expert's email address and phone number are easily accessed through this website by request.
Name variants:
Jackie Britts,
Jacky Britts,
Bud Britts
Last updated May 20, 2024
Contact Information
Last Update
Jul 9, 2022
Email
ja**@earthlink.net
Location
Greensboro, NC
Company
Azova Health
Workplace
Board Member
Work History
Member Board of Directors
7107 Industrial Rd, Florence, KY 41042
Healthcare Investor and Advisor
from Jan 2017
Co-Ceo, Chief Operations Officer and Member of the Board of Directors
Dermatologic pharmaceuticals, contract manufacturing, OTC and Rx derm
2012 — 2015
Group Vice President
84 Waterford Dr, Marlborough, MA 01752
Vice President Sepracor, Marlborough MA
2000 — 2007
Vice President, Gastroenterology Ta
Nexium, GI Therapeutics 5.5B USD franchise
1999 — 2000
General Manager
CEETMEA
Central and Eastern Europe, Turkey, Middle East and Africa
All therapeutic areas
1996 — 1999
Primary Care Group Manager
Respiratory, Cardiovascular, Neuroscience 1.5B USD Franchise
1994 — 1996
Education
1978 — 1982
Occupations
Executive
Board Member
Investor
Advisor
Management Team Executive
Operations Manager
Skills
Pharmaceutical Industry
Gastroenterology
Pharmaceutical Sales
Product Launch
Dermatology
Neurology
Managed Care
Sales Effectiveness
Cardiology
Biotechnology
Urology
Healthcare
Commercialization
Medical Devices
Clinical Development
Hospitals
Regulatory Affairs
Pulmonology
Mergers and Acquisitions
Life Sciences
Lifesciences
Strategic Alliances
Clinical Research
International Sales
International Development
Strategic Planning
Otc Commercialization
International Business
Marketing Strategy
Organizational Leadership
Pharmaceutics
Asthetics Dermatology
Pharmaceutical Patent Expiry Strategy